Research output per year
Research output per year
Personal profile
Headline
Associate Professor
Fingerprint
Dive into the research topics where Cesar Rodriguez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma
Pan, D., Mouhieddine, T. H., Sheng, T., Fu, W., Moshier, E., Richter, J., Parekh, S., Jagannath, S., Chari, A., Rossi, A. C., Sanchez, L. J., Thibaud, S., Rodriguez, C., Cho, H. J. & Richard, S., May 2026, In: Bone Marrow Transplantation. 61, 5, p. 639-641 3 p.Research output: Contribution to journal › Letter › peer-review
-
Bispecific Antibody Therapy for Multiple Myeloma: A Practical Toolkit
Rodriguez, C., Touzeau, C., Crusoe, E. D. Q., Pericole, F. V. & Hungria, V., Mar 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 3, p. 169-177 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myeloma
Rajeeve, S., Wilkes, M., Zahradka, N., Tomalin, L., Quidwai, M., Pan, D., Calafat, N. J., Cusack, M., Aleman, A., Serebryakova, K., Kappes, K., Jackson, H., Agte, S., Thibaud, S., Sanchez, L., Richard, S., Richter, J., Rodriguez, C., Cho, H. J. & Chari, A. & 4 others, , 5 May 2026, In: JCI insight. 11, 12, e203988.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression
Vieira dos Santos, J., Melnekoff, D. T., Aleman, A., Mouhieddine, T. H., Montes de Oca, R., Wang, F., Rajeeve, S., Bhalla, S., Van Oekelen, O., Upadhyaya, B., Ghodke-Puranik, Y., Leshchenko, V., Kim-Schulze, S., Rahman, A., Afik, S., Lewinsky, H., Plaks, V., Thibaud, S., Cho, H. J. & Richter, J. & 9 others, , 10 Feb 2026, In: Blood advances. 10, 3, p. 604-607 4 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A plain language summary of the final analysis of the GRIFFIN study of daratumumab plus lenalidomide, bortezomib, and dexamethasone for people with newly diagnosed multiple myeloma
Voorhees, P. M., Sborov, D. W., Laubach, J., Kaufman, J. L., Reeves, B., Rodriguez, C., Silbermann, R., Costa, L. J., Anderson, L. D., Nathwani, N., Shah, N., Bumma, N., Efebera, Y. A., Holstein, S. A., Costello, C., Jakubowiak, A., Wildes, T. M., Orlowski, R. Z., Shain, K. H. & Cowan, A. J. & 8 others, , 2025, In: Future Oncology. 21, 1, p. 25-49 25 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Recent Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Multiple Myeloma (Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab)
Moshier, E., Sastow , D., Richter, J., Lancman, G., Parekh, S., Jagannath, S., Chari, A., Cho, H. & Rodriguez, C.
30/04/26
1 item of Media coverage
Press/Media
-
FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma
27/01/26
1 item of Media coverage
Press/Media
-
Researchers' Work from Icahn School of Medicine at Mount Sinai Focuses on Hematopoiesis (Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen-Directed Chimeric ...)
Moshier, E., Richter, J., Cho, H. & Rodriguez, C.
23/10/25
1 item of Media coverage
Press/Media
-
CAR-T, an intravenous infusion achieves up to 17-year survival among multiple myeloma patients
6/09/25
1 item of Media coverage
Press/Media